Preoperative Neutrophil to Lymphocyte Ratio Predicts Complications After Esophageal Resection That can be Used as Inclusion Criteria for Enhanced Recovery After Surgery

术前中性粒细胞与淋巴细胞比值可预测食管切除术后并发症,可作为加速康复外科的纳入标准。

阅读:1

Abstract

BACKGROUND: The neutrophil to lymphocyte ratio (NLR) has been reported as an indicator for poor prognosis in many cancers including esophageal cancer. However, the relationship between the NLR and postoperative complications after esophageal cancer resection remains unclear. At present, enhanced recovery after surgery (ERAS) lacks inclusion criteria. The aim of this study is to determine whether the preoperative NLR ((pre)NLR) can predict complications after esophageal cancer resection, which could represent the criteria for ERAS. METHODS: This was a retrospective study on 171 patients who underwent esophagectomy at Hospital between November 2020 and November 2021(68 patients from Changhai Hospital, 65 patients from Shanghai General Hospital and 38 patients from Affiliated Hospital of Qingdao University). Univariate and multivariate logistic regression analyses were performed to demonstrate that the (pre)NLR could predict complications after esophagectomy. RESULTS: A (pre)NLR cutoff value of 2.30 was identified as having the greatest ability to predict complications with a sensitivity of 76% and specificity of 65%. Moreover, the Chi-squared test results showed that the (pre)NLR was significantly associated with complications (x(2 )= 13.641, p < 0.001), and multivariate logistic regression analysis showed that body mass index (BMI), p stage and (pre)NLR were independent variables associated with the development of postoperative complications (p < 0.05). CONCLUSION: The (pre)NLR can predict complications after esophagectomy, and these predicted complications can represent the criteria for recruiting patients for ERAS.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。